Skip to content

Clinical trials

Observational Leiomyoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leiomyoma Phase: Observational Country / region: United States Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20031
20052
20061
20081
20092
20102
20131
20141
20152
20162
20181
20203
20213
20221
20234
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting5
Terminated4
Withdrawn4
Active, not recruiting3
Unknown status3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Environmental Health Sciences (NIEHS)4
AbbVie2
Allergan2
Duke University2
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)2
Mayo Clinic2
Sumitomo Pharma Switzerland GmbH2
U.S. Army Medical Research and Development Command2
Ascher-Walsh, Charles, M.D.1
Baptist Health South Florida1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leiomyoma34
Myofibroma5
Endometriosis4
Menorrhagia4
Neoplasms3
Infertility2
Myoma2
Ovarian Cysts2
Ovarian Neoplasms2
Pregnancy Complications2

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.